Clin2
NCT07626034Possibly a fitNot yet recruiting

Brain scan study for schizophrenia treatment

Schizophrenia Disorder

Part of Mental health clinical trials.

This study uses a special brain scan to see how well a new medication attaches to brain receptors. It may help find better treatments for schizophrenia.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
9 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You have a body mass index (BMI) between 19 and 35.
  • You have been diagnosed with schizophrenia and are currently stable.
  • You are willing to stay in the hospital for the study.
  • You can speak and read English well enough to give informed consent.
  • You are not pregnant, breastfeeding, or planning to become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07850102Not yet recruiting· Phase 2
Brain scans for schizophrenia in adults

This study uses brain scans (MRI) to look at brain activity in people with schizophrenia. It helps researchers understand the condition better, and you do not receive any treatment.

Baltimore, Maryland
NCT07715253Not yet recruiting· Phase 1
Brain scans to study dopamine receptors in schizophrenia

This study looks at how a specific type of brain receptor (dopamine-3) works in people with schizophrenia using special brain scans (PET). Researchers want to see how these receptors behave when you are not taking antipsychotic medication, which may help guide future treatments.

NCT06969755Recruiting· Phase 4
Brain scans and genetics to guide early schizophrenia treatment

This study tests whether using brain scans and genetic tests can help choose the best treatment for people early in their schizophrenia. It will check if these biomarkers can predict who will respond better to medication.

Birmingham, Alabama
NCT03911726Recruiting
Brain imaging study of antipsychotic effects in schizophrenia

This study uses PET and MRI scans to see how antipsychotic medications affect the brain's dopamine system in people with schizophrenia, compared to healthy individuals. It may help understand if these medications cause changes that lead to worsening symptoms over time.

Mannheim, Baden-Wurttemberg
NCT06978881Enrolling by invitation
Brain activity study for stable schizophrenia

This study uses a brain scan called magnetoencephalography (MEG) to understand brain activity in people with schizophrenia. It may help researchers learn more about the condition and could lead to better treatments.

Montreal, Quebec
NCT04807530Recruiting
MRI brain study for people with schizophrenia symptoms

This study uses brain scans to look at how a specific brain area works in schizophrenia. If you qualify, it may help researchers better understand the brain changes linked to symptoms.

San Francisco, California

Hear when a new Schizophrenia Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.